Hepatic Artery Embolization Enhances Expression of Programmed Cell Death 1 Ligand 1 in an Orthotopic Rat Hepatocellular Carcinoma Model: In Vivo and in Vitro Experimentation

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero, Laura Kulik, Claude B. Sirlin et al. · Hepatology · 2018 · 4.6K citations · Full text

Medicine, Internal Medicine, Oncology +17

Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma

Qiang Gao, Xiaoying Wang, Shuang‐Jian Qiu et al. · Clinical Cancer Research · 2009 · 818 citations · Full text

Life Sciences, Immunology, Oncology +17

A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells

Ivraym B. Barsoum, Chelsea A. Smallwood, D. Robert Siemens et al. · Cancer Research · 2013 · 768 citations · Full text

Medicine, Immunology, Oncology +17

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

Julien Caldéraro, Benoı̂t Rousseau, Giuliana Amaddeo et al. · Hepatology · 2016 · 440 citations · Full text

Medicine, Oncology, Pharmacology +17

Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing

Eric Metzen, Utta Berchner‐Pfannschmidt, Petra Stengel et al. · Journal of Cell Science · 2003 · 430 citations

Life Sciences, Cell Biology, Molecular Biology +13